Market Overview:
The global cytogenetic systems market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of genetic disorders, rising demand for personalized medicine, and technological advancements in cytogenetic systems. Based on type, the global cytogenetic systems market is segmented into fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), flow cytometry, and multiplex-FISH. FISH held the largest share of the global cytogenetic systems market in 2017 owing to its high accuracy and ability to detect minute changes in chromosomes. Based on application, the global cytogenetic systems market is segmented into neoplastic diseases, genetic disorders, and personalized medicine. Neoplastic diseases accounted for the largest share of the global cytogenetics system market in 2017 due to increasing incidence of cancer worldwide. Geographically, North America held a dominant position in terms of revenue contribution followed by Europe and Asia Pacific respectively during 2017-2018 period; however Asia Pacific is projected as fastest growing region over forecast period 2018-2030 owing rapid adoption rate & penetration levels for advanced technologies coupled with presence major players such as Abbott Laboratories Inc.
Product Definition:
A cytogenetic system is a set of techniques used to study the structure and organization of chromosomes. Cytogenetics is the branch of genetics that deals with the study of chromosomes and their inheritance. The importance of cytogenetic systems is that they allow us to understand how genetic information is organized and passed from one generation to the next.
Fluorescence in Situ Hybridization:
FISH (fluorescence in situ hybridization) is a technique used for visualizing and analyzing specific DNA sequences. It involves the use of probes that are labeled with either fluorescent or radioactive substances. The probe binds to the desired DNA sequence and then an enzyme called fluorophore is used to attach the probe to a particular spot on a slide, which can be observed under ultraviolet light for fluorescence.
Global Fluorescence in Situ Hybridization, it's usage.
Comparative Genomic Hybridization:
The global market for Comparative Genomic Hybridization and it's usage in cytogenetic systems is expected to witness significant growth over the forecast period. The major drivers of this market are increasing prevalence of cancer, rising R&D activities pertaining to genomics, and presence of supportive regulatory framework in emerging economies such as India & China.
Application Insights:
The application segment includes neoplastic diseases, genetic disorders, and personalized medicine. Neoplastic diseases segment dominated the market in 2017 owing to the rising prevalence of cancer worldwide. According to WHO, it is estimated that about 1 in 6 people will develop cancer during their lifetime and over 8 million people are diagnosed with new cases every year. Moreover, an increase in the number of research initiatives by major players for developing new diagnostic techniques for various cancers is expected to drive this application segment over the forecast period.
Personalized Medicine based on cytogenetics has a significant potential to revolutionize healthcare delivery system thereby augmenting growth rate of this market during future years. Cytogenetic analysis-based tests are increasingly being used for personalizing medication treatment options through pharmacogenomics or pharmacometrics methods leading to improved patient compliance and reduced costs associated with healthcare delivery systems which augments growth rate of this market during future years significantly.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a well-established healthcare infrastructure, availability of advanced diagnostic techniques, and high adoption rate for technologically advanced products & services. Moreover, government support for R&D activities pertaining to cytogenetics is also expected to propel regional growth over the forecast period. For instance, according to NCBI; National Center for Biotechnology Information (NCBI), U.S.-based research entities have received funding worth USD X million from the National Cancer Institute (NCI) between 2011 and 2015 related to cancer-related genetic analysis of blood samples from patients diagnosed with various cancers in U.S.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing its large population base suffering from genetic disorders or tumorsigenic cancers coupled with untapped opportunities.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of cancer and other genetic disorders
- Technological advancements in cytogenetic systems and increasing demand for automated systems
- Growing public and private sector funding for research on genetic disorders
- Increasing awareness about the benefits of early diagnosis and treatment of genetic disorders
Scope Of The Report
Report Attributes
Report Details
Report Title
Cytogenetic Systems Market Research Report
By Type
Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Flow Cytometry, Multiplex-Fluorescence in Situ Hybridization
By Application
Neoplastic Diseases, Genetic Disorders, Personalized Medicine
By Companies
Genial Genetics, MetaSystems, Cytocell, Applied Spectral Imaging, PerkinElmer, Abbott Laboratories, ADS Biotec, Laboratory Imaging s.r.o., Agilent Technologies, Leica Biosystems Nussloch GmbH., Irvine Scientific, Bio-Rad Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Cytogenetic Systems Market Report Segments:
The global Cytogenetic Systems market is segmented on the basis of:
Types
Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Flow Cytometry, Multiplex-Fluorescence in Situ Hybridization
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Neoplastic Diseases, Genetic Disorders, Personalized Medicine
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Genial Genetics
- MetaSystems
- Cytocell
- Applied Spectral Imaging
- PerkinElmer
- Abbott Laboratories
- ADS Biotec
- Laboratory Imaging s.r.o.
- Agilent Technologies
- Leica Biosystems Nussloch GmbH.
- Irvine Scientific
- Bio-Rad Laboratories
Highlights of The Cytogenetic Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fluorescence in Situ Hybridization
- Comparative Genomic Hybridization
- Flow Cytometry
- Multiplex-Fluorescence in Situ Hybridization
- By Application:
- Neoplastic Diseases
- Genetic Disorders
- Personalized Medicine
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cytogenetic Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cytogenetic systems are a type of classification system used to organize and group cells based on their genetic makeup. Cytogenetic systems can be divided into two main categories: nuclear DNA (nDNA) and mitochondrial DNA (mtDNA).
Some of the major players in the cytogenetic systems market are Genial Genetics, MetaSystems, Cytocell, Applied Spectral Imaging, PerkinElmer, Abbott Laboratories, ADS Biotec, Laboratory Imaging s.r.o., Agilent Technologies, Leica Biosystems Nussloch GmbH., Irvine Scientific, Bio-Rad Laboratories.
The cytogenetic systems market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cytogenetic Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cytogenetic Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cytogenetic Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cytogenetic Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cytogenetic Systems Market Size & Forecast, 2020-2028
4.5.1 Cytogenetic Systems Market Size and Y-o-Y Growth
4.5.2 Cytogenetic Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Fluorescence in Situ Hybridization
5.2.2 Comparative Genomic Hybridization
5.2.3 Flow Cytometry
5.2.4 Multiplex-Fluorescence in Situ Hybridization
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Neoplastic Diseases
6.2.2 Genetic Disorders
6.2.3 Personalized Medicine
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cytogenetic Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cytogenetic Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Fluorescence in Situ Hybridization
9.6.2 Comparative Genomic Hybridization
9.6.3 Flow Cytometry
9.6.4 Multiplex-Fluorescence in Situ Hybridization
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Neoplastic Diseases
9.10.2 Genetic Disorders
9.10.3 Personalized Medicine
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Fluorescence in Situ Hybridization
10.6.2 Comparative Genomic Hybridization
10.6.3 Flow Cytometry
10.6.4 Multiplex-Fluorescence in Situ Hybridization
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Neoplastic Diseases
10.10.2 Genetic Disorders
10.10.3 Personalized Medicine
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Fluorescence in Situ Hybridization
11.6.2 Comparative Genomic Hybridization
11.6.3 Flow Cytometry
11.6.4 Multiplex-Fluorescence in Situ Hybridization
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Neoplastic Diseases
11.10.2 Genetic Disorders
11.10.3 Personalized Medicine
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Fluorescence in Situ Hybridization
12.6.2 Comparative Genomic Hybridization
12.6.3 Flow Cytometry
12.6.4 Multiplex-Fluorescence in Situ Hybridization
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Neoplastic Diseases
12.10.2 Genetic Disorders
12.10.3 Personalized Medicine
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Fluorescence in Situ Hybridization
13.6.2 Comparative Genomic Hybridization
13.6.3 Flow Cytometry
13.6.4 Multiplex-Fluorescence in Situ Hybridization
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Neoplastic Diseases
13.10.2 Genetic Disorders
13.10.3 Personalized Medicine
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cytogenetic Systems Market: Competitive Dashboard
14.2 Global Cytogenetic Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Genial Genetics
14.3.2 MetaSystems
14.3.3 Cytocell
14.3.4 Applied Spectral Imaging
14.3.5 PerkinElmer
14.3.6 Abbott Laboratories
14.3.7 ADS Biotec
14.3.8 Laboratory Imaging s.r.o.
14.3.9 Agilent Technologies
14.3.10 Leica Biosystems Nussloch GmbH.
14.3.11 Irvine Scientific
14.3.12 Bio-Rad Laboratories
